BYSI
Closed
Beyondspring Inc
2.42
+0.07 (+2.98%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 2.35
Day's Range: 2.385 - 2.5
Send
sign up or login to leave a comment!
When Written:
1.12
BeyondSpring Inc is a clinical-stage biopharmaceutical company focused on the development of innovative cancer therapies. The company's lead product candidate, Plinabulin, is a small molecule that has shown promising results in preclinical and clinical studies for the treatment of various types of cancer, including lung cancer, breast cancer, and ovarian cancer. BeyondSpring is also developing other novel cancer therapies, including immuno-oncology agents and targeted therapies. The company is headquartered in New York City and has research and development facilities in Maryland and Shanghai, China. BeyondSpring went public in 2017 and is listed on the NASDAQ stock exchange under the ticker symbol BYSI.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








